HELE Quote, Financials, Valuation and Earnings

European Wax Center has a net margin of -121.27% compared to Helen Of Troy's net margin of 3.37%. Helen Of Troy's return on equity of -21.76% beat European Wax Center's return on equity of 9.03%.

Helen Of Troy has a consensus price target of $38.33, signalling upside risk potential of 74.72%. On the other hand European Wax Center has an analysts' consensus of $6.71 which suggests that it could grow by 37.03%. Given that Helen Of Troy has higher upside potential than European Wax Center, analysts believe Helen Of Troy is more attractive than European Wax Center.

Helen Of Troy has a beta of 0.874, which suggesting that the stock is 12.65% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Helen Of Troy quarterly revenues are $371.7M, which are larger than European Wax Center quarterly revenues of $51.4M. Helen Of Troy's net income of -$450.7M is lower than European Wax Center's net income of $1.7M. Notably, Helen Of Troy's price-to-earnings ratio is 4.45x while European Wax Center's PE ratio is 24.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.27x versus 1.03x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of -121.27% compared to Helen Of Troy's net margin of -14.51%. Helen Of Troy's return on equity of -21.76% beat The Beauty Health's return on equity of -66.39%.

Helen Of Troy has a consensus price target of $38.33, signalling upside risk potential of 74.72%. On the other hand The Beauty Health has an analysts' consensus of $1.66 which suggests that it could grow by 4.4%. Given that Helen Of Troy has higher upside potential than The Beauty Health, analysts believe Helen Of Troy is more attractive than The Beauty Health.

Helen Of Troy has a beta of 0.874, which suggesting that the stock is 12.65% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $371.7M, which are larger than The Beauty Health quarterly revenues of $69.6M. Helen Of Troy's net income of -$450.7M is lower than The Beauty Health's net income of -$10.1M. Notably, Helen Of Troy's price-to-earnings ratio is 4.45x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.27x versus 0.66x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast PLC has a net margin of -121.27% compared to Helen Of Troy's net margin of --. Helen Of Troy's return on equity of -21.76% beat Waldencast PLC's return on equity of -5.64%.

Helen Of Troy has a consensus price target of $38.33, signalling upside risk potential of 74.72%. On the other hand Waldencast PLC has an analysts' consensus of $3.98 which suggests that it could grow by 73.04%. Given that Helen Of Troy has higher upside potential than Waldencast PLC, analysts believe Helen Of Troy is more attractive than Waldencast PLC.

Helen Of Troy has a beta of 0.874, which suggesting that the stock is 12.65% less volatile than S&P 500. In comparison Waldencast PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. Waldencast PLC pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $371.7M, which are larger than Waldencast PLC quarterly revenues of --. Helen Of Troy's net income of -$450.7M is higher than Waldencast PLC's net income of --. Notably, Helen Of Troy's price-to-earnings ratio is 4.45x while Waldencast PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.27x versus 0.92x for Waldencast PLC. Usually stocks with elevated PS ratios are considered overvalued.